U.S. gives final clearance to COVID-19 shots for kids 5 to 11

Summary by KSL

U.S. health officials on Tuesday gave the final signoff to Pfizer's kid-size COVID-19 shot, a major expansion of the nation's vaccination campaign.

Published 2 years ago · Washington, United States

News Articles

More
Filters

All

Left

Center

Right

Yahoo News

US poised for final approval of Pfizer's Covid vaccine for children aged 5-11

An expert panel unanimously recommended Pfizer-BioNTech's Covid vaccine for five- to 11-year-olds on Tuesday, the penultimate step in the process that will allow injections in young children to begin this week in the United States.

2 years ago·Los Angeles, United States

Read Full Article

News18 India

US Gives Final Clearance to Covid-19 Shots for Kids Aged Between 5 and 11

The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine.

2 years ago·India

Read Full Article

Reuters

U.S. CDC director backs COVID-19 vaccine for children ages 5 to 11

The director of the U.S. Centers for Disease Control and Prevention (CDC) on Tuesday backed broad use of Pfizer's and BioNTech's COVID-19 vaccine in children ages 5 to 11, clearing the way for shots to go into young arms as soon as Wednesday.

2 years ago·United Kingdom

Read Full Article

The Hindu

U.S. gives final clearance to COVID-19 shots for kids 5 to 11

The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine

2 years ago·India

Read Full Article

CTV News

U.S. gives final clearance to COVID-19 shots for kids 5 to 11

U.S. health officials on Tuesday gave the final signoff to Pfizer's kid-size COVID-19 shot, a major expansion of the nation's vaccination campaign. The Food and Drug Administration already authorized the shots for children ages 5 to 11 -- doses just a third of the amount given to teens and adults. But the Centers for Disease Control and Prevention recommends who should receive FDA-cleared vaccines.

2 years ago·Toronto, Canada

Read Full Article